These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Clinical study of the month. Effects of valsartan in chronic heart failure: the VAL-HeFT study]. Piérard L Rev Med Liege; 2002 Jan; 57(1):57-9. PubMed ID: 11899501 [TBL] [Abstract][Full Text] [Related]
24. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems. Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215 [TBL] [Abstract][Full Text] [Related]
25. Valsartan for the treatment of heart failure. Latini R; Masson S; Staszewsky L; Maggioni AP Expert Opin Pharmacother; 2004 Jan; 5(1):181-93. PubMed ID: 14680446 [TBL] [Abstract][Full Text] [Related]
38. Cardiac protection: evolving role of angiotensin receptor blockers. Califf RM; Cohn JN Am Heart J; 2000 Jan; 139(1 Pt 2):S15-22. PubMed ID: 10618583 [TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of valsartan versus enalapril in heart failure patients. Willenheimer R; Helmers C; Pantev E; Rydberg E; Löfdahl P; Gordon A; Int J Cardiol; 2002 Oct; 85(2-3):261-70. PubMed ID: 12208593 [TBL] [Abstract][Full Text] [Related]
40. Valsartan: a review of its use in patients with heart failure and/or left ventricular systolic dysfunction after myocardial infarction. Croom KF; Keating GM Am J Cardiovasc Drugs; 2004; 4(6):395-404. PubMed ID: 15554725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]